Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;25(5):701-704.
doi: 10.1007/s11102-022-01222-2. Epub 2022 May 26.

How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing)

Carla Scaroni  1   2   3 , Alessandro Mondin  4   5 , Filippo Ceccato  4   5
Affiliations

How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing)

Carla Scaroni et al. Pituitary. 2022 Oct.
No abstract available

Keywords: CRH test; Cushing’s syndrome; Desmopressin test; dexamethasone-CRH test; pseudo-Cushing’s syndrome.

PubMed Disclaimer

Conflict of interest statement

All authors declare that they have no conflicts of interest for this topic that might be perceived as influencing the impartiality of the reported research.

References

    1. Findling JW, Raff H, DIAGNOSIS OF ENDOCRINE DISEASE Differentiation of pathologic/neoplastic hypercortisolism (Cushing’s syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing’s syndrome) Eur J Endocrinol. 2017;176(5):R205–R216. doi: 10.1530/EJE-16-0946. - DOI - PubMed
    1. Scaroni C, Albiger NM, Palmieri S, et al. Approach to patients with pseudo-Cushing’s states. Endocr Connect. 2020;9(1):R1–R13. doi: 10.1530/EC-19-0435. - DOI - PMC - PubMed
    1. Petersenn S. Biochemical diagnosis of Cushing’s disease: Screening and confirmatory testing. Best Pract Res Clin Endocrinol Metab. 2021;35(1):101519. doi: 10.1016/j.beem.2021.101519. - DOI - PubMed
    1. Yanovski JA, Cutler GB, Jr, Chrousos GP, Nieman LK. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing’s syndrome from pseudo-Cushing’s states. JAMA. 1993;269(17):2232–2238. doi: 10.1001/jama.1993.03500170062035. - DOI - PubMed
    1. Nieman L, Editorial The dexamethasone-suppressed corticotropin-releasing hormone test for the diagnosis of Cushing’s syndrome: what have we learned in 14 years? J Clin Endocrinol Metab. 2007;92(8):2876–2878. doi: 10.1210/jc.2007-1289. - DOI - PubMed

LinkOut - more resources